About VaxForm
VaxForm is a company based in Lehigh (United States) founded in 2010. VaxForm offers products and services including QYNDR Platform and Oral COVID Vaccine. VaxForm operates in a competitive market with competitors including Neovacs, Fina Biosolutions, VERAXA, Yapanbio and Intravacc, among others.
- Headquarter Lehigh, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Vaxform Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$256 K (USD), Grant
Sep 01, 2020
-
Investors
NIH
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of VaxForm
VaxForm offers a comprehensive portfolio of products and services, including QYNDR Platform and Oral COVID Vaccine.
Technology for creating oral COVID vaccines through research and innovation.
Vaccine designed to prevent COVID-19 via oral administration.
People of VaxForm
Unlock access to complete
Unlock access to complete
Funding Insights of VaxForm
Investors in VaxForm
VaxForm has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include NIH and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Locked | Locked | Locked | |
|
Drug discovery services are provided to the biopharma sector.
|
Locked | Locked | Locked |
Investor details for VaxForm
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by VaxForm
Investment portfolio details for VaxForm
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - VaxForm
Detailed financials for VaxForm
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vaxform Comparisons
Peer comparison for VaxForm
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of VaxForm
VaxForm operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Neovacs, Fina Biosolutions, VERAXA, Yapanbio and Intravacc, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Vaccine manufacturing services are provided by Neovacs CDMO.
|
|
| Locked | Locked | Locked |
Biotechnology company specializing in bioconjugation services mainly for vaccine development
|
|
| Locked | Locked | Locked |
Antibody therapeutics for cancer treatment are developed via microfluidic screening.
|
|
| Locked | Locked | Locked |
Contract manufacturing of bio-therapeutics and vaccines is provided.
|
|
| Locked | Locked | Locked |
Vaccine development services for bacterial and viral vaccines are provided.
|
|
| Locked | Locked | Locked |
New molecules are discovered, developed, and manufactured in biotechnology.
|
Detailed competitors of VaxForm
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vaxform
Complete news archive for VaxForm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about VaxForm
VaxForm was founded in 2010.
VaxForm is headquartered in Lehigh, United States.
VaxForm is exclusively focused on the development of vaccine products and their formulations. It also provides consulting services in the area of vaccine formulation development and assists its clients through the different phases of vaccine formulation development right from preclinical stage to commercialization. They offer their services right from project definition to implementation for mono- or multivalent bacterial or viral antigen formulations, vaccine combinations, and live attenuated vaccines. The company claims to have expertise in the formulation of vaccine targets including Pneumococcal recombinant proteins, Combination vaccines, and Staph enterotoxins. VaxForm has signed RD agreements from United States Army Medical Research Institute for infectious diseases and Tamarisk Technologies (an early stage drug delivery technology company). VaxForm has also received Small Business Technology Transfer Program (STTR) grants from the US DoD to develop a recombinant fusion protein vaccine targeting diseases resulting from Streptococcus pyogenes infection.
VaxForm offers QYNDR Platform and Oral COVID Vaccine.
VaxForm has 2 investors. Key investors include NIH, and National Science Foundation.